Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/8/2025

Management of Premixed Insulin Regimens

Initiation and Dosing

  • The American College of Physicians recommends initiating insulin-naïve patients with 10 units or 0.1-0.2 units/kg of body weight of Novolin 70/30, typically divided into two daily doses 1
  • Administer Novolin 70/30 twice daily, 30 minutes before breakfast and dinner, as recommended by the American Diabetes Association 2, 3

Dose Titration

  • Adjust doses based on self-monitoring of blood glucose levels, with a target fasting blood glucose of 90-150 mg/dL for most patients, as recommended by the American Association of Clinical Endocrinologists 1, 4, 5
  • If 50% of fasting fingerstick glucose values are over target, increase dose by 2 units, as suggested by the American Diabetes Association 4
  • If more than 2 fasting fingerstick values per week are below target, decrease dose by 2 units, as recommended by the American Association of Clinical Endocrinologists 4, 5

Monitoring and Safety

  • Monitor for hypoglycemia, which is the most common adverse effect of insulin therapy, as warned by the American College of Physicians 1, 2
  • Do not use rapid-acting insulin at bedtime to avoid nocturnal hypoglycemia, as advised by the American Diabetes Association 4, 5
  • Evaluate glycemic control every 2 weeks and adjust therapy as needed, as recommended by the American Association of Clinical Endocrinologists 5

Alternative Regimens to Consider

  • If glycemic targets are not achieved with Novolin 70/30 twice daily, consider advancing to thrice-daily premixed insulin or switching to a basal-bolus regimen, as suggested by the American Diabetes Association 2, 6
  • Adding a GLP-1 receptor agonist to basal insulin may be considered for patients not achieving targets, as recommended by the American Association of Clinical Endocrinologists 6

Common Pitfalls and Caveats

  • Premixed insulins like Novolin 70/30 offer less flexibility in dose adjustment compared to separate basal and bolus insulins, as noted by the American College of Physicians 2
  • The fixed ratio (70/30) may not be optimal for all patients, particularly those with varying insulin requirements throughout the day, as warned by the American Diabetes Association 1, 2

Blood Glucose Monitoring Frequency with 70/30 Insulin

  • The American Diabetes Association recommends checking blood glucose at least 4 times per day, before breakfast, before dinner, at bedtime, and when suspecting low blood sugar, for individuals taking 70/30 insulin 7
  • Checking blood glucose before breakfast, before dinner, and at bedtime is crucial to assess overnight glucose control, evaluate daytime glucose control, and prevent nocturnal hypoglycemia, respectively, for individuals taking 70/30 insulin 7, 8
  • Testing blood glucose when suspecting low blood sugar is essential for individuals taking premixed insulins like 70/30, which carry a significant hypoglycemia risk 7

Additional Testing Situations

  • The American Diabetes Association recommends testing blood glucose after treating low blood sugar until glucose normalizes, for individuals taking 70/30 insulin 7
  • Testing blood glucose before exercise is necessary to prevent exercise-induced hypoglycemia, for individuals taking 70/30 insulin 7
  • Testing blood glucose before critical tasks like driving is necessary to ensure safety, for individuals taking 70/30 insulin 7

Key Monitoring Targets

  • The American Diabetes Association recommends a fasting glucose goal of 90-130 mg/dL for individuals taking 70/30 insulin 9
  • The American Diabetes Association recommends a peak postprandial glucose target of <180 mg/dL for individuals taking 70/30 insulin 9

Critical Safety Considerations

  • The American Diabetes Association emphasizes the importance of never skipping bedtime testing to prevent nocturnal hypoglycemia, particularly common with 70/30 insulin due to the NPH component's overnight action 7
  • Testing blood glucose more frequently than 4 times daily is recommended during dose adjustments or regimen changes, or when experiencing frequent hypoglycemia or unstable glucose control, for individuals taking 70/30 insulin 7, 8